Approach
We don’t run programs.
We build momentum.
Biolytics is crafted specifically for founders who have progressed beyond the initial stages of startup development, such as pitch decks and investor presentations.
These are the innovators who have already validated their ideas, built early prototypes, and are now seeking real-world opportunities to scale their ventures. At this stage, it’s no longer about showcasing potential—it’s about demonstrating traction and readiness to engage with industry stakeholders on a deeper level.
These are the innovators who have already validated their ideas, built early prototypes, and are now seeking real-world opportunities to scale their ventures. At this stage, it’s no longer about showcasing potential—it’s about demonstrating traction and readiness to engage with industry stakeholders on a deeper level.
Our values
Tailored Growth Support
Custom growth support aligned to each company’s lifecycle
Strategic Market Access
Commercial and public sector introductions that matter
Regulatory & Systems Navigation
Regulatory, policy, and health system navigation
Fundraising Support
Fundraising advisory, investor connects, and capital strategy
We engage selectively, invest deeply, and support until scale is achieved.
How we engage
1.
Submit your interest through our online form
2.
Reviewed by a panel of experts from IIT Bombay, Stanford Biodesign, and the healthcare industry
3.
If aligned, we co-design a roadmap focused on scale, capital, and access
4.
Strategic support kicks in based on company goals and go-to-market priorities
5.
No batches, no deadlines — just real growth
Sectors we work in
Digital Health
MedTech & Devices
Diagnostics
Public Health Tech
Healthcare Infrastructure
Success stories
Diagnostics Startup to Market Leader
Scaled from prototype to multi-hospital deployment, secured first public procurement contract.
Enabling Health Platform for Government
National program onboarding after Biolytics strategy support and policy positioning.
Global MedTech
Entry
Strategy, regulatory, and distribution support for commercial launch in India.
Growth Capital
Access
A digital therapeutics company raised a successful pre-seed round after Biolytics-led investor readiness advisory.